RELENTLESS PLACOID CHORIORETINITIS: SUCCESSFUL LONG-TERM TREATMENT WITH INTRAVITREAL TRIAMCINOLONE.

Published on Feb 1, 2017in Retinal Cases & Brief Reports
· DOI :10.1097/ICB.0000000000000546
Daniel B. Roth18
Estimated H-index: 18
(UMDNJ: University of Medicine and Dentistry of New Jersey),
D. B. Roth5
Estimated H-index: 5
(UMDNJ: University of Medicine and Dentistry of New Jersey)
+ 2 AuthorsHoward F Fine16
Estimated H-index: 16
Sources
Abstract
PURPOSE: To report a case of relentless placoid chorioretinitis (ampiginous choroiditis) treated with intravitreal triamcinolone acetonide (IVTA). METHODS: Interventional case report. RESULTS: A 34-year-old pregnant woman with a history of poor visual acuity in her left eye, secondary to an undetermined cause, developed an acute painless central scotoma and blurred vision in the right eye. The examination revealed decreased visual acuity, active inflammatory placoid choroidal lesions in the posterior pole, and mid-periphery with sharp disk margins and normal-appearing vasculature. A diagnosis of relentless placoid chorioretinitis was made, and the patient was treated biannually with 4 mg IVTA for 3 years with visual improvement to 20/25. Although she experienced a relapse at 12 months, the episode was adequately controlled with repeat IVTA. After the sixth IVTA treatment occurring at 30 months, the decision was made to stop IVTA, ultimately facilitating the preservation of 20/25 in the right eye at 63-month follow-up. The disease course was complicated by cataract progression that was successfully treated with a cataract extraction and episodic increases in intraocular pressure which were successfully treated with timolol ophthalmic solution. CONCLUSION: Intravitreal triamcinolone acetonide therapy represents an important alternative in the treatment of relentless placoid chorioretinitis. By avoiding the potentially significant side effects of long-term systemic corticosteroid and immunosuppressive therapies, IVTA can be an important alternative in the long-term management of this uncommon and complicated entity.
📖 Papers frequently viewed together
4 Citations
8 Citations
25 Citations
References0
Newest
#1Emmanouil Mavrikakis (UHN: University Health Network)H-Index: 4
#2Wai Ching Lam (UHN: University Health Network)H-Index: 23
Abstract The aim of this article is to provide a current update on the use of intravitreal steroids as a treatment option for a variety of retinal diseases and to review the current literature in regard to their properties, safety, and adverse effects.
4 CitationsSource
#1Steven YehH-Index: 33
#2Julie C. LewH-Index: 6
Last. Robert B. NussenblattH-Index: 99
view all 4 authors...
10 CitationsSource
12 CitationsSource
#1Biswas Jyotirmay (SN: Sankara Nethralaya)H-Index: 2
#2Shafiq S. Jafferji (SN: Sankara Nethralaya)H-Index: 1
Last. Badami KalpanaH-Index: 1
view all 4 authors...
The purpose of this study was to report the clinical profile and management of patients with serpiginous choroiditis in a tertiary care referral center in India. In a retrospective cohort study, 107 eyes of 70 patients with serpiginous choroiditis seen between January 1995 and December 2002 were analyzed. Systemic steroids and immunosuppressives were the mainstay of therapy. Antituberculous and antiviral drugs were used in selected cases. There was male preponderance (7:3). Age at presentation r...
51 CitationsSource
Purpose: To assess the efficacy and complications of intravitreal triamcinolone acetonide (IVTA) injection in the treatment of posterior uveitis and to compare the outcomes with patients who had received systemic corticosteroids. Methods: This prospective, interventional, clinical case series study included 11 eyes of 9 patients who received 8 mg/0.2 ml of IVTA injection for posterior uveitis that involved vitreous inflammation (group 1). Control group (group 2) consisted of 15 eyes of 12 patien...
19 CitationsSource
#1Ufuk Adigüzel (Mersin University)H-Index: 9
#2Ayça Sari (Mersin University)H-Index: 9
Last. Özay Öz (Mersin University)H-Index: 10
view all 4 authors...
Purpose: To report the efficacy of intravitreal triamcinolone acetonide injection for acute treatment of a patient with serpiginous choroiditis. Methods: A 50-year-old male patient with serpiginous choroiditis presenting with the complaint of decreased visual acuity in his right eye for the last 10 days. The best corrected visual acuity (BCVA) of the patient was counting finger from 1 meter. Fundus examination and fundus fluorescein angiography of right eye revealed active macular choroiditis in...
9 CitationsSource
#1Tadashi Orihara (Kyorin University)H-Index: 4
#2Toshiko Wakabayashi (Kyorin University)H-Index: 7
Last. Tetsuo Hida (Kyorin University)H-Index: 27
view all 7 authors...
Jones and colleagues described a clinical entity they called relentless placoid chorioretinitis, characterized by features similar to both acute posterior multifocal placoid pigment epitheliopathy (APMPPE) and serpiginouschoroiditis, but with atypical features for either of these diseases. 1 Here we describe a young Japanese man with what we believe fits their description of relentless placoid chorioretinitis.
5 CitationsSource
#1Esen K. Akpek (MEE: Massachusetts Eye and Ear Infirmary)H-Index: 44
#2Stefanos Baltatzis (Athens State University)H-Index: 24
Last. C. Stephen Foster (MEE: Massachusetts Eye and Ear Infirmary)H-Index: 104
view all 4 authors...
Objective: To determine the efficacy of immunosuppressive treatment in serpiginous choroiditis. Design: The clinical courses were reviewed of six consecutive patients (12 eyes) with vision-threatening, steroid-dependent/resistant serpiginous choroiditis treated with a combination of immunosuppressive agents including azathioprine, cyclosporine, and cyclophosphamide. All patients underwent treatment for at least 12 months. Results: The follow-up period ranged from 17 to 105 months (mean 57, media...
52 CitationsSource
#1B. Eric Jones (U of C: University of Chicago)H-Index: 1
#2Lee M. Jampol (U of C: University of Chicago)H-Index: 78
Last. David F. WilliamsH-Index: 25
view all 8 authors...
Objective: To characterize an unusual clinical entity resembling acute posterior multifocal placoid pigment epitheliopathy (APMPPE) and serpiginous choroiditis but with an atypical clinical course. Patients: We describe 6 patients, aged 17 through 51 years, exhibiting this unusual entity who were seen at 6 different centers from 1984 to 1997. Results: The acute retinal lesions in this series were similar to those of APMPPE or serpiginous choroiditis, both clinically and on fluorescein and indocy...
89 Citations
Cited By4
Newest
#1Alessandro MarcheseH-Index: 11
#2Aniruddha Agarwal (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 23
Last. Giuseppe CasalinoH-Index: 12
view all 9 authors...
Placoid lesions of the retina may be secondary to a wide spectrum of acquired inflammatory conditions that have been reported as single entities with different presentation and clinical course. These conditions include acute posterior multifocal placoid pigment epitheliopathy, persistent placoid maculopathy, serpiginous choroiditis, serpiginous-like choroiditis, relentless placoid chorioretinitis and acute syphilitic posterior placoid chorioretinitis. In this article, we will group these conditi...
Source
Source
#1Isil Kutluturk (University of Bern)H-Index: 1
#2Aniruddha Agarwal (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 23
Last. Marion R. Munk (University of Bern)H-Index: 12
view all 15 authors...
ABSTRACTPurpose: Placoid-pigment-epitheliopathies like Acute-Posterior-Multifocal-Placoid-Pigment Epitheliopathy (APMPPE) and Relentless-Placoid-Choroidopathy (RPC) usually show bilateral involveme...
1 CitationsSource
#2Rukhsana G. MirzaH-Index: 11
Last. Lee M. JampolH-Index: 78
view all 3 authors...
Source